Our work is entirely funded by private donations – we receive no money from government. Your money will help us continue funding research into vitiligo and supporting people affected by the condition.
Washington, DC (USA)
An interactive session for clinicians and patients will be held during the spring congress of the American Academy of Dermatology in Washington, DC:
- White spot on the skin: vitiligo or not?
- Vitiligo Triggers. A review of the most common external causes for vitiligo.
- How Can I Cure Vitiligo? An easy question without an answer.
- Medical treatments for vitiligo: first, second and third-line approach.
- Natural treatments for vitiligo. Do they ever work?
- Loss of skin pigment: is it reversible or not? Relapse is quite common.
- Depigmenting skin with vitiligo. What's safe?
Vitiligo is not only an under-investigated, poorly understood skin disease that affects 1-2% of the population. From the clinician’s perspective, vitiligo is often seen as a pigmentary disorder that has no common treatment protocol, no disease-specific drugs, no insurance coverage, and a lengthy off-label therapy with high dropout rate and poor outcomes. From the patients’ perspective, vitiligo is a loathed disease that causes a great deal of suffering in life and requires an expensive treatment, with little hope for cure. We’ll review in a rapid-fire mode a 1-2-3 step treatment approach, reveal unseen correlations with other factors and offer tips for clinicians and patients.
Session co-chairs: Prof. Katlein França, President of Association for Psychoneurocutaneous Medicine of North America, and Prof. Torello Lotti, University of Guglielmo Marconi (Italy)
The session will be held one day before the main AAD meeting, on February 28, 2019. Details are forthcoming.
- I have a new job - should I tell colleagues about my vitiligo?
If you are starting a new job and you are concerned about stares and questions about your skin, try a proactive approach. When the time is right and you are feeling comfortable,...
- What's better: laser or phototherapy?
In a recent study researchers assessed effect and safety of different laser and phototherapy treatments, such as excimer laser/light, narrowband UVB, UVA and PUVA. No significa...
- Will it spread?
Vitiligo activity may vary considerably from person to person. In a good number of patients the disease goes on for 3-4 years and then it settles down, with one or two stubborn...
Though it is not always easy to treat vitiligo, there is much to be gained by clearly understanding the diagnosis, the future implications, treatment options and their outcomes.
Many people deal with vitiligo while remaining in the public eye, maintaining a positive outlook, and having a successful career.Copyright (C) Bodolóczki Júlia
By taking a little time to fill in the anonymous questionnaire, you can help researchers better understand and fight vitiligo.